MedTrace Logo

AVIDA The Vidaza® (Azacitidine) Patient Registry

NCT00481273 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 479

Last updated 2018-05-03

No results posted yet for this study

Summary

This registry is a prospective, multi-center, observational study compiling data on the natural history and management of patients receiving Vidaza, and will provide unique insights into the management of myelodysplastic syndromes (MDS) and other hematological disorders and the impact of these disorders on patients.

Conditions

Interventions

DRUG

Azacitidine

Physician's discretion

Sponsors & Collaborators

  • Celgene

    lead INDUSTRY

Principal Investigators

  • David L. Grinblatt, MD · Endeavor Health

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00481273 on ClinicalTrials.gov